Market Overview

Frazier Healthcare Partners Adds Two Experienced Professionals to Life Sciences Team


Frazier Healthcare Partners announced the addition of two new members to
its Life Sciences team: Tracy Saxton, Ph.D. as an
Entrepreneur-in-Residence (EIR), and Vanessa Bhark as a Senior Associate.

As an EIR, Dr. Saxton will focus on company creation efforts. She is the
founder and CEO of Aucupo Biosciences, a newly formed Frazier search
company focused on identifying novel therapeutics for patients with
unmet medical need. Prior to joining Frazier, Dr. Saxton held investment
positions with Pivotal bioVenture Partners, the Roche Venture Fund (RVF)
and SV Life Sciences Advisers (SVLSA), where she focused on the
biopharmaceutical sector. Dr. Saxton previously held positions at
Tularik (acquired by Amgen) and Threshold Pharmaceuticals. She began her
career as a drug discovery scientist and moved to leadership roles in
Regulatory Affairs, Clinical Development and Project Management.

As a Senior Associate, Ms. Bhark will focus on evaluating investments
and creating new ventures in life sciences. Prior to joining Frazier,
she was in Corporate Development at Gilead Sciences, where she
structured and led the negotiation of licenses, collaborations, and
acquisitions across therapeutic areas. Previously, Ms. Bhark was a
Business Development Manager at Janssen, the Pharmaceutical Companies of
Johnson & Johnson, where she led the evaluation and recommendation of
licensing and acquisition opportunities for Janssen's $3.2 billion
Infectious Disease Franchise. In addition, she worked for Morgan Stanley
in the Equity Research Division with a focus on public biotech

"We are excited to have Tracy and Vanessa join our team; collectively,
they bring significant skill sets in venture, drug development, and
business development to the life sciences venture group," said Jamie
Topper, M.D., Ph.D., Managing General Partner with the Frazier Life
Sciences team.

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of
growth and venture capital to healthcare companies. With nearly $4.2
billion total capital raised, Frazier has invested in over 170
companies, with investment types ranging from company creation and
venture capital to buyouts of profitable lower-middle market companies.
The firm's Growth Buyout team invests in healthcare and pharmaceutical
services, medical products and related sectors. The Life Sciences team
invests in therapeutics and related areas that are addressing unmet
medical needs through innovation. Frazier has offices in Seattle, WA and
Menlo Park, CA, and invests broadly across the US, Canada, and Europe.

For more information about Frazier Healthcare Partners, visit the
company's website at

About Aucupo Biosciences, Inc.

Headquartered in Menlo Park, CA, Aucupo Biosciences is a newly formed
Frazier search company focused on identifying novel therapeutics for
patients with unmet medical need.

View Comments and Join the Discussion!